Why study gene-environment interactions?

Current Opinion in Lipidology

Volumn 19, Issue 2, 2008, Pages 158-167

  Ordovas, Jose M ^a   Tai, E Shyong ^b  

^a TUFTS UNIVERSITY   (United States)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Alcohol drinking; Diet; Exercise; Gene environment interaction; Plasma lipids; Smoking

Indexed keywords

APOLIPOPROTEIN A2; APOLIPOPROTEIN A5; TRIACYLGLYCEROL;

ALCOHOL CONSUMPTION; CARDIOVASCULAR DISEASE; COFFEE; DIET; ENVIRONMENTAL FACTOR; FOOD INTAKE; GENOTYPE ENVIRONMENT INTERACTION; HUMAN; NUTRITION; OBSERVATIONAL STUDY; PHYSICAL ACTIVITY; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; RISK FACTOR; SAMPLE SIZE; SMOKING; STATISTICAL ANALYSIS;

DIET; ENVIRONMENT; GENETICS; HABITS; HUMANS; LIFE STYLE; RISK FACTORS;

EID: 41649111313     PISSN: 09579672     EISSN: None     Source Type: Journal    
DOI: 10.1097/MOL.0b013e3282f6a809     Document Type: Review

References (71)

1. Smith U. TCF7L2 and type 2 diabetes: we WNT to know. Diabetologia 2007; 50:5-7.
2. Zeggini E, McCarthy MI. TCF7L2: the biggest story in diabetes genetics since HLA? Diabetologia 2007; 50:1-4.
3. Tracy R. Characterizing populations in the era of genomics and systems biology. Curr Opin Lipidol 2008; 19:151-157.
4. Li S, Loos RJF. Progress in the genetics of common obesity - size matters. Curr Opin Lipidol 2008; 19:113-121.
5. Li H, Wu Y, Loos RJ, et al. Variants in the fat mass and obesity-associated (FTO) gene are not associated with obesity in a Chinese Han population. Diabetes 2008; 57:264-268.
6. Andreasen CH, Stender-Petersen KL, Mogensen MS, et al. Low physical activity accentuates the effect of the FTO rs9939609 polymorphism on body fat accumulation. Diabetes 2008; 57:95-101.
7. van Dam RM, Hu FB. Coffee consumption and risk of type 2 diabetes: a systematic review. JAMA 2005; 294:97-104.
8. Pereira MA, Parker ED, Folsom AR. Coffee consumption and risk of type 2 diabetes mellitus: an 11-year prospective study of 28 812 postmenopausal women. Arch Intern Med 2006; 166:1311-1316.
9. van Dam RM, Willett WC, Manson JE, Hu FB. Coffee, caffeine, and risk of type 2 diabetes: a prospective cohort study in younger and middle-aged U.S. women. Diabetes Care 2006; 29:398-403.
10. Campos H, Baylin A. Coffee consumption and risk of type 2 diabetes and heart disease. Nutr Rev 2007; 65:173-179.
11. Kondo I, Berg K, Drayna D, Lawn R. DNA polymorphismat the locus for human cholesteryl ester transfer protein (CETP) is associated with high density lipoprotein cholesterol and apolipoprotein levels. Clin Genet 1989; 35:49-56.
12. Talmud PJ. Gene-environment interaction and its impact on coronary heart disease risk. Nutr Metab Cardiovasc Dis 2007; 17:148-152.
13. Manfredi S, Federici C, Picano E, et al. GSTM1, GSTT1 and CYP1A1 detoxification gene polymorphisms and susceptibility to smoking-related coronary artery disease: a case-only study. Mutat Res 2007; 621:106-112.
14. Saijo Y, Yoshioka E, Fukui T, et al. Effects of the interaction between interleukin-6-634C/G polymorphism and smoking on serum C-reactive protein concentrations. Hypertens Res 2007; 30:593-599.
15. Jang Y, Koh SJ, Kim OY, et al. Effect of the 252A>G polymorphism of the lymphotoxin-alpha gene on inflammatory markers of response to cigarette smoking in Korean healthy men. Clin Chim Acta 2007; 377:221-227.
16. North KE, Carr JJ, Borecki IB, et al. QTL-specific genotype-by-smoking interaction and burden of calcified coronary atherosclerosis: the NHLBI Family Heart Study. Atherosclerosis 2007; 193:11-19.
17. Goldenberg I, Moss AJ, Block R, et al. Polymorphism in the cholesteryl ester transfer protein gene and the risk of early onset myocardial infarction among cigarette smokers. Ann Noninvasive Electrocardiol 2007; 12:364-374.
18. Cornelis MC, El-Sohemy A, Campos H. GSTT1 genotype modifies the association between cruciferous vegetable intake and the risk of myocardial infarction. Am J Clin Nutr 2007; 86:752-758.
19. Stephens JW, Dhamrait SS, Mani AR, et al. Interaction between the uncoupling protein 2-866G>A gene variant and cigarette smoking to increase oxidative stress in subjects with diabetes. Nutr Metab Cardiovasc Dis 2008; 18:7-14.
20. Gambier N, Marteau JB, Batt AM, et al. Interaction between CYP1A1 T3801C and AHR G1661A polymorphisms according to smoking status on blood pressure in the Stanislas cohort. J Hypertens 2006; 24:2199-2205.
21. Lee CR, North KE, Bray MS, et al. NOS3 polymorphisms, cigarette smoking, and cardiovascular disease risk: the Atherosclerosis Risk in Communities study. Pharmacogenet Genomics 2006; 16:891-899.
22. Hannuksela ML, Liinamaa MJ, Kesaniemi YA, Savolainen MJ. Relation of polymorphisms in the cholesteryl ester transfer protein gene to transfer protein activity and plasma lipoprotein levels in alcohol drinkers. Atherosclerosis 1994; 110:35-44.
23. Beulens JW, Rimm EB, Hendriks HF, et al. Alcohol consumption and type 2 diabetes: influence of genetic variation in alcohol dehydrogenase. Diabetes 2007; 56:2388-2394.
24. Jensen MK, Mukamal KJ, Overvad K, Rimm EB. Alcohol consumption, TaqIB polymorphism of cholesteryl ester transfer protein, high-density lipoprotein cholesterol, and risk of coronary heart disease in men and women. Eur Heart J 2007; 29:104-112.
25. Volcik K, Ballantyne CM, Pownall HJ, et al. Interaction effects of high-density lipoprotein metabolism gene variation and alcohol consumption on coronary heart disease risk: the Atherosclerosis Risk In Communities study. J Stud Alcohol Drugs 2007; 68:485-492.
26. Tsujita Y, Nakamura Y, Zhang Q, et al. The association between high-density lipoprotein cholesterol level and cholesteryl ester transfer protein TaqIB gene polymorphism is influenced by alcohol drinking in a population-based sample. Atherosclerosis 2007; 191:199-205.
27. Grove ML, Morrison A, Folsom AR, et al. Gene-environment interaction and the GNB3 gene in the Atherosclerosis Risk in Communities study. Int J Obes (Lond) 2007; 31:919-926.
28. Kilpelainen TO, Lakka TA, Laaksonen DE, et al. Physical activity modifies the effect of SNPs in the SLC2A2 (GLUT2) and ABCC8 (SUR1) genes on the risk of developing type 2 diabetes. Physiol Genomics 2007; 31:264-272.
29. Rankinen T, Church T, Rice T, et al. Effect of endothelin 1 genotype on blood pressure is dependent on physical activity or fitness levels. Hypertension 2007; 50:1120-1125.
30. Nelson TL, Fingerlin TE, Moss LK, et al. Association of the peroxisome proliferator-activated receptor gamma gene with type 2 diabetes mellitus varies by physical activity among non-Hispanic whites from Colorado. Metabolism 2007; 56:388-393.
31. Cornelis MC, El-Sohemy A, Campos H. Genetic polymorphism of the adenosine A2A receptor is associated with habitual caffeine consumption. Am J Clin Nutr 2007; 86:240-244.
32. Ordovas JM, Corella D. Nutritional genomics. Annu Rev Genomics Hum Genet 2004; 5:71-118.
33. Corella D, Ordovas JM. Single nucleotide polymorphisms that influence lipid metabolism: interaction with dietary factors. Annu Rev Nutr 2005; 25:341-390.
34. Corella D, Lai CQ, Demissie S, et al. APOA5 gene variation modulates the effects of dietary fat intake on body mass index and obesity risk in the Framingham Heart Study. J Mol Med 2007; 85:119-128.
35. Robitaille J, Houde A, Lemieux S, et al. Variants within the muscle and liver isoforms of the carnitine palmitoyltransferase I (CPT1) gene interact with fat intake to modulate indices of obesity in French-Canadians. J Mol Med 2007; 85:129-137.
36. Li TY, Zhang C, Asselbergs FW, et al. Interaction between dietary fat intake and the cholesterol ester transfer protein TaqIB polymorphism in relation to HDL-cholesterol concentrations among US diabetic men. Am J Clin Nutr 2007; 86:1524-1529.
37. Morcillo S, Rojo-Martinez G, Cardona F, et al. Effect of the interaction between the fatty acid binding protein 2 gene Ala54Thr polymorphism and dietary fatty acids on peripheral insulin sensitivity: a cross-sectional study. Am J Clin Nutr 2007; 86:1232-1237.
38. Shen J, Arnett DK, Peacock JM, et al. Interleukin 1 beta genetic polymorphisms interact with polyunsaturated fatty acids to modulate risk of the metabolic syndrome. J Nutr 2007; 137:1846-1851.
39. Sofi F, Fatini C, Sticchi E, et al. Fish intake and LPA 93C>T polymorphism: gene-environment interaction in modulating lipoprotein (a) concentrations. Atherosclerosis 2007; 195:e147-e154.
40. Scacchi R, Pinto A, Rickards O, et al. An analysis of peroxisome proliferator-activated receptor gamma (PPAR-gamma 2) Pro12Ala polymorphism distribution and prevalence of type 2 diabetes mellitus (T2DM) in world populations in relation to dietary habits. Nutr Metab Cardiovasc Dis 2007; 17:632-641.
41. Santos JL, Boutin P, Verdich C, et al. Genotype-by-nutrient interactions assessed in European obese women. A case-only study. Eur J Nutr 2006; 45:454-462.
42. Hubacek JA, Bohuslavova R, Skodova Z, et al. Polymorphisms in the APOA1/C3/A4/A5 gene cluster and cholesterol responsiveness to dietary change. Clin Chem Lab Med 2007; 45:316-320.
43. Moreno-Luna R, Perez-Jimenez F, Marin C, et al. Two independent apolipoprotein A5 haplotypes modulate postprandial lipoprotein metabolism in a healthy Caucasian population. J Clin Endocrinol Metab 2007; 92:2280-2285.
44. Corella D, Arnett DK, Tsai MY, et al. The -256T>C polymorphism in the apolipoprotein A-II gene promoter is associated with body mass index and food intake in the genetics of lipid lowering drugs and diet network study. Clin Chem 2007; 53:1144-1152. Apolipoprotein A-II has remained for decades an enigmatic protein. Despite being the second most abundant protein in HDL, its physiologic role remains unknown. This study supports a role of apolipoprotein A-II as a modulator of dietary choices and body weight.
45. Delgado-Lista J, Perez-Jimenez F, Tanaka T, et al. An apolipoprotein A-II polymorphism (-265T/C, rs5082) regulates postprandial response to a saturated fat overload in healthy men. J Nutr 2007; 137:2024-2028.
46. Perez-Martinez P, Perez-Jimenez F, Ordovas JM, et al. Postprandial lipemia is modified by the presence of the APOB-516C/T polymorphism in a healthy Caucasian population. Lipids 2007; 42:143-150.
47. Tanaka T, Ordovas JM, Delgado-Lista J, et al. Peroxisome proliferator-activated receptor alpha polymorphisms and postprandial lipemia in healthy men. J Lipid Res 2007; 48:1402-1408.
48. Tanaka T, Delgado-Lista J, Lopez-Miranda J, et al. Scavenger receptor class B type I (SCARB1) c.1119C>T polymorphism affects postprandial triglyceride metabolism in men. J Nutr 2007; 137:578-582.
49. Perez-Martinez P, Perez-Jimenez F, Ordovas JM, et al. The APOB -516C/T polymorphism is associated with differences in insulin sensitivity in healthy males during the consumption of diets with different fat content. Br J Nutr 2007; 97:622-627.
50. Perez-Martinez P, Perez-Jimenez F, Ordovas JM, et al. The APOB -516C/T polymorphism has no effect on lipid and apolipoprotein response following changes in dietary fat intake in a healthy population. Nutr Metab Cardiovasc Dis 2007; 17:224-229.
51. Fernandez de la Puebla RA, Perez-Martinez P, Carmona J, et al. Factor VII polymorphisms influence the plasma response to diets with different fat content, in a healthy Caucasian population. Mol Nutr Food Res 2007; 51:618-624.
52. Santosa S, Demonty I, Lichtenstein AH, et al. Single nucleotide polymorphisms in ABCG5 and ABCG8 are associated with changes in cholesterol metabolism during weight loss. J Lipid Res 2007; 48:2607-2613.
53. Nelson TL, Stevens JR, Hickey MS. Adiponectin levels are reduced, independent of polymorphisms in the adiponectin gene, after supplementation with alpha-linolenic acid among healthy adults. Metabolism 2007; 56:1209-1215.
54. Lai CQ, Arnett DK, Corella D, et al. Fenofibrate effect on triglyceride and postprandial response of apolipoprotein A5 variants: the GOLDN study. Arterioscler Thromb Vasc Biol 2007; 27:1417-1425.
55. Erkkila AT, Schwab US, Agren JJ, et al. Moderate increase in dietary sucrose does not influence fasting or postprandial serum lipids regardless of the presence of apolipoprotein E2 allele in healthy subjects. Eur J Clin Nutr 2007; 61:1094-1101.
56. Weiss EP, Brandauer J, Kulaputana O, et al. FABP2 Ala54Thr genotype is associated with glucoregulatory function and lipid oxidation after a high-fat meal in sedentary nondiabetic men and women. Am J Clin Nutr 2007; 85:102-108.
57. Helwig U, Rubin D, Klapper M, et al. The association of fatty acid-binding protein 2 A54T polymorphism with postprandial lipemia depends on promoter variability. Metabolism 2007; 56:723-731.
58. Robitaille J, Houde A, Lemieux S, et al. The lipoprotein/lipid profile is modulated by a gene-diet interaction effect between polymorphisms in the liver X receptor-alpha and dietary cholesterol intake in French-Canadians. Br J Nutr 2007; 97:11-18.
59. Nieminen T, Matinheikki J, Nenonen A, et al. The relationship of sterol regulatory element-binding protein cleavage-activation protein and apolipoprotein E gene polymorphisms with metabolic changes during weight reduction. Metabolism 2007; 56:876-880.
60. Boks MP, Schipper M, Schubart CD, et al. Investigating gene environment interaction in complex diseases: increasing power by selective sampling for environmental exposure. Int J Epidemiol 2007; 36:1363-1369.
61. Chanda P, Zhang A, Brazeau D, et al. Information-theoretic metrics for visualizing gene-environment interactions. Am J Hum Genet 2007; 81:939-963.
62. Zhang L, Mukherjee B, Ghosh M, et al. Accounting for error due to mis-classification of exposures in case-control studies of gene-environment interaction. Stat Med 2007 [Epub ahead of print].
63. Bureau A, Diallo MS, Ordovas JM, Cupples LA. Estimating interaction between genetic and environmental risk factors: efficiency of sampling designs within a cohort. Epidemiology 2008; 19:83-93.
64. Teo YY. Common statistical issues in genome-wide association studies: a review on power, data quality control, genotype calling, and population structure. Curr Opin Lipidol 2008; 19:133-143.
65. Servin B, Stephens M. Imputation-based analysis of association studies: candidate regions and quantitative traits. PLoS Genet 2007; 3:e114.
66. Marchini J, Howie B, Myers S, et al. A new multipoint method for genome-wide association studies by imputation of genotypes. Nat Genet 2007; 39:906-913.
67. Williamson DA, Allen HR, Martin PD, et al. Comparison of digital photography to weighed and visual estimation of portion sizes. J Am Diet Assoc 2003; 103:1139-1145.
68. Bingham SA. Biomarkers in nutritional epidemiology. Public Health Nutr 2002; 5:821-827.
69. Baylin A, Campos H. The use of fatty acid biomarkers to reflect dietary intake. Curr Opin Lipidol 2006; 17:22-27.
70. Kornman K, Rogus J, Roh-Schmidt H, et al. Interleukin-1 genotype-selective inhibition of inflammatory mediators by a botanical: a nutrigenetics proof of concept. Nutrition 2007; 23:844-852.
71. Arkadianos I, Valdes AM, Marinos E, et al. Improved weight management using genetic information to personalize a calorie controlled diet. Nutr J 2007; 6:29.